HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283,704,698 | +3.6% | 3,167,054 | -1.5% | 0.06% | +9.6% |
| Q2 2023 | $273,887,888 | -7.5% | 3,216,912 | -10.1% | 0.05% | -11.9% |
| Q1 2023 | $296,138,583 | -6.7% | 3,578,714 | -11.3% | 0.06% | -7.8% |
| Q4 2022 | $317,333,324 | -20.1% | 4,034,753 | -24.8% | 0.06% | -24.7% |
| Q3 2022 | $397,274,000 | +8.1% | 5,366,399 | -4.8% | 0.08% | +14.9% |
| Q2 2022 | $367,491,000 | -5.7% | 5,638,084 | -8.6% | 0.07% | +10.4% |
| Q1 2022 | $389,776,000 | +44.8% | 6,165,363 | +21.5% | 0.07% | +55.8% |
| Q4 2021 | $269,117,000 | -10.2% | 5,073,879 | +19.5% | 0.04% | -15.7% |
| Q3 2021 | $299,606,000 | +21.8% | 4,244,307 | +15.0% | 0.05% | +24.4% |
| Q2 2021 | $245,981,000 | +55.2% | 3,691,189 | +158.6% | 0.04% | +46.4% |
| Q1 2021 | $158,449,000 | -2.2% | 1,427,334 | +4.6% | 0.03% | -6.7% |
| Q4 2020 | $162,014,000 | +47.0% | 1,364,333 | +8.0% | 0.03% | +30.4% |
| Q3 2020 | $110,237,000 | -20.0% | 1,263,452 | -17.9% | 0.02% | -25.8% |
| Q2 2020 | $137,788,000 | -38.6% | 1,538,498 | -31.7% | 0.03% | -47.5% |
| Q1 2020 | $224,474,000 | -61.9% | 2,252,392 | -56.1% | 0.06% | -52.4% |
| Q4 2019 | $589,624,000 | -18.1% | 5,131,634 | -10.1% | 0.12% | -23.5% |
| Q3 2019 | $719,699,000 | -0.1% | 5,705,555 | -4.7% | 0.16% | +1.9% |
| Q2 2019 | $720,195,000 | +38.7% | 5,984,670 | +0.8% | 0.16% | +34.7% |
| Q1 2019 | $519,273,000 | +4.9% | 5,935,913 | +20.0% | 0.12% | -4.8% |
| Q4 2018 | $495,020,000 | -8.0% | 4,947,734 | +5.4% | 0.12% | +9.7% |
| Q3 2018 | $537,960,000 | +183.6% | 4,695,052 | +122.0% | 0.11% | +169.0% |
| Q2 2018 | $189,698,000 | -16.7% | 2,115,273 | -32.0% | 0.04% | -19.2% |
| Q1 2018 | $227,653,000 | +3.3% | 3,111,728 | -18.0% | 0.05% | +6.1% |
| Q4 2017 | $220,279,000 | +12.6% | 3,792,684 | -13.0% | 0.05% | +8.9% |
| Q3 2017 | $195,642,000 | +15.2% | 4,360,204 | +1.3% | 0.04% | +12.5% |
| Q2 2017 | $169,900,000 | -0.1% | 4,302,355 | +2.6% | 0.04% | -2.4% |
| Q1 2017 | $170,084,000 | +23.8% | 4,192,350 | +22.6% | 0.04% | +20.6% |
| Q4 2016 | $137,415,000 | +11.7% | 3,418,261 | +0.6% | 0.03% | +9.7% |
| Q3 2016 | $123,008,000 | +68.5% | 3,397,063 | +34.9% | 0.03% | +63.2% |
| Q2 2016 | $73,008,000 | +6.5% | 2,518,369 | +28.5% | 0.02% | +5.6% |
| Q1 2016 | $68,554,000 | +14.1% | 1,959,806 | +5.2% | 0.02% | +12.5% |
| Q4 2015 | $60,077,000 | +24.9% | 1,863,426 | +25.2% | 0.02% | +23.1% |
| Q3 2015 | $48,106,000 | -32.9% | 1,488,436 | -14.1% | 0.01% | -27.8% |
| Q2 2015 | $71,651,000 | -0.4% | 1,732,384 | +8.2% | 0.02% | 0.0% |
| Q1 2015 | $71,937,000 | +37.5% | 1,601,444 | +14.6% | 0.02% | +28.6% |
| Q4 2014 | $52,304,000 | +1.0% | 1,397,761 | -5.7% | 0.01% | 0.0% |
| Q3 2014 | $51,784,000 | +0.2% | 1,482,921 | +1.2% | 0.01% | 0.0% |
| Q2 2014 | $51,674,000 | +86.2% | 1,464,691 | +72.0% | 0.01% | +75.0% |
| Q1 2014 | $27,746,000 | +253.3% | 851,391 | +356.7% | 0.01% | +300.0% |
| Q4 2013 | $7,854,000 | +7.6% | 186,422 | +1.9% | 0.00% | 0.0% |
| Q3 2013 | $7,298,000 | -0.3% | 183,022 | +3.4% | 0.00% | 0.0% |
| Q2 2013 | $7,317,000 | – | 176,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |